Abzena Expands its Microbiology Laboratory Space for Biologic Manufacturing
The expansion of the QC microbiology lab is part of Abzena's broader strategy to help alleviate and address the market demand for quality testing, which has been driven by increased regulatory requirements, and provides a future-forward approach to streamlining biopharmaceutical innovations.
Biotechnology | 04/11/2024 | By Aishwarya
Duke Street Bio Gets EMA Approval to Launch PARP1-Selective Inhibitor Trial
This potentially best-in-class, potent, highly selective and CNS-penetrant agent targets cancers that harbour homologous recombination deficiencies (HRD) including BRCA mutations.
Biotechnology | 25/09/2024 | By Aishwarya | 130
Indian Govt Approves Bio-RIDE Scheme to Accelerate R&D in Biotechnology
The proposed outlay for the implementation of the unified scheme ‘Bio-RIDE’ is INR 9197 crore during the 15th Finance Commission period from 2021-22 to 2025-26.
Biotechnology | 19/09/2024 | By Aishwarya | 120
NATCO Pharma Announces Investment of USD 8 Million in eGenesis
The eGenesis Genome Engineering and Production (EGEN) Platform is the only technology to comprehensively address cross-species molecular incompatibilities and viral risk via genetic engineering to improve the lives of patients in need of a transplant.
Biotechnology | 04/09/2024 | By Aishwarya | 122
EUROAPI and Priothera to Advance Oncology Project
EUROAPI has begun the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules for the treatment of hematological malignancies and for the improvement of CAR-T cell therapies.
Biotechnology | 20/06/2024 | By Aishwarya | 216
Northwest Biotherapeutics Bags Exclusive In-License of Dendritic Cell Technology
Northwest Biotherapeutics has announced an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).
Biotechnology | 18/06/2024 | By Aishwarya | 213
NSG BioLabs and Eppendorf Group to Support Biotech Companies in Singapore
NSG BioLabs has collaborated with Eppendorf to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development (R&D).
Biotechnology | 13/06/2024 | By Aishwarya | 201
Limula Secures USD 6.8 Million in Oversubscribed Seed Round
Limula has raised USD 6.8 million to take their solution for automating cell therapy manufacturing to the next stage of development.
Biotechnology | 22/05/2024 | By Aishwarya | 109
GVSAP Join Hands with Biocytogen to Accelerate Biopharmaceutical Innovation
GV Safety Assessment Platform (GVSAP) has forged a groundbreaking partnership with Biocytogen, a leader in industry-leading technologies that propel drug discovery.
Biotechnology | 20/05/2024 | By Aishwarya | 138
Siren Biotechnology and Catalent to Manufacture AAV Gene Therapies for Cancer
Siren Biotechnology has signed a strategic partnership with Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
Biotechnology | 18/05/2024 | By Aishwarya | 193
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy